Vicki L. Traina-Dorge
Vicki Traina-Dorge was born in Havre de Grace, Md, USA in 1950. She received a B.S. degree in biology and medical technology from Jacksonville State University, Ala, USA in 1972 and a Ph.D. degree in microbiology and immunology from Tulane University, La, USA, in 1983. She was a Research Fellow in Biochemistry at LSU Medical Center, La, USA from 1983 to 1987 and a Research Associate in Microbiology at Tulane University National Primate Research Center from 1987 to 1989. She joined the Tulane Microbiology Faculty in 1989 and is currently a Research Associate Professor of microbiology. As a Molecular Virologist, her research interests focused on the biology and genetics of virus infections in the nonhuman primate, as well as the efficacy of vaccines and therapeutics to combat those infections for multiple virus systems that include: HTLV/STLV, HIV/SIV, SVV, RSV, RhPV, and VEE. Within this diverse program, she has extensive expertise in evaluating genetic, virologic, immunologic, and pathologic responses in the development of simian animal models of viral disease. Her current program focuses on 1) delineation of immunopathological mechanisms of SVV reactivation as a model of shingles; 2) development of an RhPV model for therapeutic testing; 3) AIDS vaccine development with SVV-based-SIV and VEE-based-SIV vaccines. Her work has successfully received extramural funding and resulted in the publication of numerous peer-reviewed manuscripts in well-respected scientific journals. In addition, she serves as a Reviewer of multiple scientific journals, as well as a Panel Reviewer on NIH-NIAID Study Section Review Panels for AIDS Vaccine Development (1997) and Anthrax Vaccine Development (2003, 2004). She currently serves on the Tulane University Institutional Biosafety Committee and Radiation Safety Committee. Traina-Dorge is a Member of Sigma Xi, American Society for Microbiology, American Association for the Advancement of Science, and the International Retrovirology Association.
Biography Updated on 4 October 2011